Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.03 USD | -3.42% | -0.40% | -30.72% |
Financials (USD)
Sales 2024 * | 279M | Sales 2025 * | 322M | Capitalization | 599M |
---|---|---|---|---|---|
Net income 2024 * | -69M | Net income 2025 * | -58M | EV / Sales 2024 * | -0.72 x |
Net cash position 2024 * | 800M | Net cash position 2025 * | 755M | EV / Sales 2025 * | -0.48 x |
P/E ratio 2024 * |
-8.67
x | P/E ratio 2025 * |
-10.6
x | Employees | 1,184 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 61.71% |
Latest transcript on Fulgent Genetics, Inc.
1 day | -3.42% | ||
1 week | -0.40% | ||
Current month | -7.70% | ||
1 month | -9.53% | ||
3 months | -22.84% | ||
6 months | -18.68% | ||
Current year | -30.72% |
Managers | Title | Age | Since |
---|---|---|---|
Ming Hsieh
CEO | Chief Executive Officer | 68 | 16-05-12 |
James Xie
FOU | Founder | 58 | 16-05-12 |
Paul Kim
DFI | Director of Finance/CFO | 56 | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ming Hsieh
CEO | Chief Executive Officer | 68 | 16-05-12 |
Linda Marsh
BRD | Director/Board Member | 74 | 19-07-31 |
Regina Groves
BRD | Director/Board Member | 66 | 23-01-02 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.30% | 27 M€ | -5.44% | - | |
0.26% | 29 M€ | -4.59% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 20.03 | -3.42% | 184,147 |
24-04-24 | 20.74 | +0.48% | 152,597 |
24-04-23 | 20.64 | +0.39% | 144,249 |
24-04-22 | 20.56 | +0.98% | 158,429 |
24-04-19 | 20.36 | +1.24% | 156,226 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.72% | 620M | |
-17.52% | 8.34B | |
+40.49% | 3.59B | |
-32.64% | 2.75B | |
-8.06% | 2.48B | |
-9.58% | 2.32B | |
-14.40% | 1.79B | |
-18.74% | 1.54B | |
-40.19% | 1.21B | |
+5.57% | 1.13B |
- Stock Market
- Equities
- FLGT Stock